Literature DB >> 7071600

Lysergic acid diethylamide (LSD) and lisuride: differentiation of their neuropharmacological actions.

F J White, J B Appel.   

Abstract

The nonhallucinogenic ergot derivative lisuride exerts many pharmacological effects that are similar to those of its hallucinogenic congener, lysergic acid diethylamide (LSD). Animals trained to discriminate between the presence of one drug and the other can be used to differentiate the actions of these compounds on a neuronal level. The discriminative stimulus effect of LSD (the LSD cue) is similar to that of the serotonin agonist quipazine, whereas the lisuride cue is similar to that of the dopamine agonist apomorphine. These data support the hypothesis that serotonin is intricately involved in the hallucinogenic effects of LSD.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7071600     DOI: 10.1126/science.7071600

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  15 in total

Review 1.  Early preclinical studies of discriminable sedative and hallucinogenic drug effects.

Authors:  Herbert Barry; James B Appel
Journal:  Psychopharmacology (Berl)       Date:  2008-08-20       Impact factor: 4.530

2.  Drug discrimination procedures: roles of relative stimulus control in two-drug cases.

Authors:  M D Swedberg; T U Järbe
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 3.  Trends in drug discrimination research analysed with a cross-indexed bibliography, 1982-1983.

Authors:  I P Stolerman; P J Shine
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 4.  Role of training dose in drug discrimination: a review.

Authors:  Ian P Stolerman; Emma Childs; Matthew M Ford; Kathleen A Grant
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

5.  Behavioral and 5-HT antagonist effects of ritanserin: a pure and selective antagonist of LSD discrimination in rat.

Authors:  F C Colpaert; T F Meert; C J Niemegeers; P A Janssen
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

6.  Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes.

Authors:  Bruce E Blough; Antonio Landavazo; Ann M Decker; John S Partilla; Michael H Baumann; Richard B Rothman
Journal:  Psychopharmacology (Berl)       Date:  2014-05-07       Impact factor: 4.530

7.  Differentiation between the stimulus effects of (+)-lysergic acid diethylamide and lisuride using a three-choice, drug discrimination procedure.

Authors:  P M Callahan; J B Appel
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 8.  Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.

Authors:  Adam L Halberstadt
Journal:  Behav Brain Res       Date:  2014-07-15       Impact factor: 3.332

9.  Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. II: Reassessment of LSD false positives.

Authors:  D Fiorella; R A Rabin; J C Winter
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

10.  LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor.

Authors:  Adam L Halberstadt; Mark A Geyer
Journal:  Psychopharmacology (Berl)       Date:  2009-11-25       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.